The global COVID-19 pandemic has resulted in an upsurge in antimicrobial use. The increase in use is multifactorial. and is particularly related to the empirical treatment of SARS-CoV-2 and suspected coinfections with antimicrobials and the limited quality of diagnostics to differentiate viral and bacterial pneumonia. The lack of clear clinical guidelines across a wide range of settings. https://www.knowall.blog/